The early study suggested that, with ensuing local inflammation of lung affected areas, secretion of the pro-inflammatory cytokines and chemokines was increasing, such as IL-6, IFNγ, M-CSF, and MCP1, and these would release into the blood of COVID-19 patients (9). This evidence concerns the gene IFNG and COVID-19.